Clinical trial testing superiority of combination plinabulin (Plin) and pegfilgrastim (Peg) versus peg alone in breast cancer treated with high-risk febrile neutropenia risk chemotherapy (chemo): Final results of the phase 3 protective-2 in chemo-induced neutropenia (CIN) prevention.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Douglas W. Blayney, Yuankai Shi, Hryhorii Adamchuk, David Feng, Qingyuan Zhang, Lihua Du, Lan Huang, Ramon Mohanlal
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3170098415
